Home
Swiss Cancer Institute

Swiss Cancer Institute Market Share Analysis for August 2026

Digitale Datenerfassung für klinische Krebsstudien: GCP-konforme EDC-Systeme, eCRFs, Datensicherheit & Studienmanagement – Swiss Cancer Institute Schweiz.

Industry: N/A

Domainswisscancerinstitute.ch

Year Founded1965

Employees51 - 200

Annual Revenue--

Swiss Cancer Institute

Swiss Cancer Institute (including company regionals)

swisscancerinstitute.ch

See more website traffic and engagement information

Total visits to Swiss Cancer Institute's top domains

Understand Swiss Cancer Institute market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

swisscancerinstitute.ch4.2K

See more with Sales Intelligence

Avg. visit duration in Swiss Cancer Institute's top domains

Analyze Swiss Cancer Institute engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

swisscancerinstitute.ch00:00:34

See more with Sales Intelligence

Avg. pageviews on Swiss Cancer Institute's top domains

See how Swiss Cancer Institute keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

swisscancerinstitute.ch1.71

See more with Sales Intelligence

Swiss Cancer Institute top competitors by domain

Top similar sites in August 2026, ranked by their affinity

rgcc-international.comCompany NameRGCC InternationalEmployees51 - 200HQPoland, GdanskAnnual revenue$5M - $10MTotal visits10.8KN/A

Top technologies used by Swiss Cancer Institute

These are the website technologies, by industry, used by Swiss Cancer Institute top domains

Social (3)

Instagram

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

Advertising (1)

DoubleClick

More Technologies

5

See all

News & Signals from Swiss Cancer Institute

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIntensity Therapeutics, Inc. partners with Swiss Cancer Institute.Intensity also initiated a Phase 2 study in collaboration with the Swiss Cancer Institute (the "INVINCIBLE-4 Study") (NCT06358573) as part of a Phase 2/3 program evaluating INT230-6 followed by the SOC immunochemotherapy and the SOC alone for patients with presurgical triple-negative breast cancer.

NewsAstraZeneca PLC partners with Swiss Cancer Institute.Transform Care Award: AstraZeneca and Swiss Cancer Institute to fund pioneering projects in oncology with CHF 30,000.